Cell Based Assays: this form of assay is one that looks at the effect of a given treatment on live cells. They measure proliferation, viability and cytotoxicity. Commonly used to monitor the response and health of cells in culture after treatment with various stimuli.
-
JUN 15, 2023 | 8:00 AM
C.E. CREDITS
ELISA (Enzyme-Linked Immunosorbent Assay) is a powerful and well-established method that enables researchers to detect and quantify a wide range of soluble substances, such as peptides, prot...
MAY 09, 2023 | 1:00 PM
C.E. CREDITS
Date: May 09, 2023 Time: 5:00am (PDT), 8:00pm (EDT), 2:00pm (CEST) Advances in high content imaging (HCI) have improved the use of cell culture to make a large number of comparisons within i...
MAR 30, 2023 | 1:50 PM
C.E. CREDITS
Liquid biopsy tests are an integral part of the molecular diagnostic workup of cancer specimens. We have performed extensive validation studies of the GeneStrat NGS test (GSNGS), that uses a...
Liquid biopsy tests are an integral part of the molecular diagnostic workup of cancer specimens. We have performed extensive validation studies of the GeneStrat NGS test (GSNGS), that uses a...
MAR 30, 2023 | 1:00 PM
C.E. CREDITS
The circulating T-cell receptor (TCR) repertoire is a dynamic representation of overall immune responses in an individual. Here we aimed to correlate pre-treatment circulating TCR repertoire...
The circulating T-cell receptor (TCR) repertoire is a dynamic representation of overall immune responses in an individual. Here we aimed to correlate pre-treatment circulating TCR repertoire...
MAR 30, 2023 | 12:25 PM
C.E. CREDITS
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
MAR 28, 2023 | 3:30 AM
C.E. CREDITS
Date: March 28, 2023 Time: 3:30am (PDT), 6:30am (EDT), 12:30pm (CEST) Biofluid-based neurological biomarkers have shown promise in helping to improve diagnostic accuracy, predict disease pro...
MAR 22, 2023 | 9:00 AM
C.E. CREDITS
We have developed 3D-shaped hydrogel microparticle platforms to capture cells, as well as isolate and label their secretions. These “lab on a particle” systems enable sorting cel...